Dr. Martine Vanlommel
ActiveSummary
Dr. Martine Vanlommel has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €253,710 and a net result of €186,457. Equity has been growing by about 22% per year since 2018. Its solvency ranks better than 31% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 06-04-2017 Normal situation
- Activity
- Specialist medical practice NACE 86220and 1 other
- Joint committee
- 330 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2022
- Establishment unit
- 2.263.113.829 3800 Sint-Truiden, since 06-04-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 17-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €275,177
- ▼ 5.9%
- Turnover
- ≈ €420,000
- estimated
- Profit
- €186,457
- ▼ 5.4%
- Equity
- €253,710
- ▼ 48.5%
- Total assets
- €669,373
- ▼ 7.4%
Score breakdownraises riskLiquidity: current ratio 1.22, cash €6,596, halvedlowers riskSector: Human health activities (NACE 86)Size: total assets €669,373Figures for financial year 2025 (filed on 16-04-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 31% of them on solvency, 3% on liquidity, 80% on profitability and 13% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 55 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Equity fell in 2025from €492,253 to €253,710 ▼ 48.5% View
- Positive: Higher net result than 86% of companies in human healthsector median €60,156 · 20,687 companies €186,457 View
- Positive: 8 profitable years in a rowprofit 2025: €186,457 8 years View
- Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View
Recent changes
- · Gazette deed Resignation: Martine VANLOMMEL (director)Reappointment: Martine VANLOMMEL (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Dr. Martine Vanlommel: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €656,000 and €745,000, founded between 2015 and 2018.
| Company | Total assets | Gross margin |
|---|---|---|
| Dr. Martine Vanlommel Hasselt | €669,373 | €275,177 |
| DOCTEUR SEVERINE DEPT Manage | €675,165 | €269,009 |
| FACIAL SURGERY Elsene | €665,880 | €276,195 |
| Bert Deylgat Heelkunde Koksijde | €744,708 | €267,145 |
| CORBIJONAS Cerfontaine | €656,291 | €268,981 |
| dr. Arne Clicteur Jabbeke | €686,643 | €277,711 |
| Dr. GHILLEMIJN T., geriatrie Oostkamp | €711,489 | €297,498 |
Key facts about Dr. Martine Vanlommel
- What is the company number of Dr. Martine Vanlommel?
- The company number of Dr. Martine Vanlommel is 0673.964.413. The VAT number is the same number with BE in front: BE 0673.964.413.
- Where is Dr. Martine Vanlommel based?
- The registered office is at Muntelbeekstraat 9, 3500 Hasselt.Company details
- What does Dr. Martine Vanlommel do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. Martine Vanlommel?
- The legal form of Dr. Martine Vanlommel is Private limited company (BV).
- When was Dr. Martine Vanlommel founded?
- Dr. Martine Vanlommel was founded on 06-04-2017.
- Is Dr. Martine Vanlommel still active?
- Yes, Dr. Martine Vanlommel is an active enterprise in the KBO register.
- How many employees does Dr. Martine Vanlommel have?
- Dr. Martine Vanlommel had an average of 0.2 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- Which joint committee does Dr. Martine Vanlommel fall under?
- In its 2022 annual accounts, Dr. Martine Vanlommel states joint committee 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
- What is the turnover of Dr. Martine Vanlommel?
- The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €275,177 and 36 comparable companies (NACE 862). It probably lies between €380,000 and €530,000.
- Is Dr. Martine Vanlommel profitable?
- In financial year 2025, Dr. Martine Vanlommel made a profit of €186,457.
- Where can I find the annual accounts of Dr. Martine Vanlommel?
- Dr. Martine Vanlommel filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Martine Vanlommel due?
- Dr. Martine Vanlommel must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.